Table 2.

Plasma levels of SR10171 and rosiglitazone at the end of experiments.

Treatment	Plasma levels
SR10171 (μM)	Rosi (μM)
C57BL6 on RD 4 days treatment: SR10171 – 5 mg/kg/d; Rosi – 5 mg/kg/d	4.01	1.67
DIO model on HFD 4 wks treatment: SR10171 – 22.1 mg/kg/d; Rosi – 24.2 mg/kg/d	14.25	0.10
C57BL/6 on RD 8 wks treatment: SR10171 – 12.7 mg/kg/d; Rosi – 11.7 mg/kg/d	15.97	6.28